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A MODEL FOR THE D IFFERENTIAT ION OF HUMAN 
NATURAL KILLER CELLS 
Studies on the In Vitro Activation of  Leu-11 + Granular  Lymphocytes 
With a Natural Killer-sensitive Tumor  Cell, K562 
BY JOSEPH H. PHILLIPS AND LEWIS L. LANIER 
From the Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043 
Natural killer (NK) 1 cells are a heterogeneous population of lymphoid cells 
from an unimmunized host that are able to lyse certain tumor cells and virally 
infected cells through a mechanism unrestricted by the major histocompatibility 
complex (MHC). Human lymphocytes with NK activity can be highly enriched 
in the low density fractions of discontinuous Percoll gradients (1). Morphological 
examination of this low density population demonstrates that the majority of 
these cells are large granular ]ymphocytes (LGL) (1). Recently (2-5), several 
murine monoclonal antibodies, including anti-Leu-11, B73.1, 3G8, and VEP 13, 
have been produced that react with essentially all human NK cells, but not T 
cells, B cells, or monocytes. Anti-Leu-11 and related mAb react with an antigen 
associated with the Fc receptor for IgG present on NK cells and neutrophils, and 
can specifically inhibit Fc receptor-mediated functions (2, 3, 5). 
Lymphoblasts with the characteristics of NK cells have been identified in 
mixed lymphocyte r sponse cultures using autologous and ailogeneic stimulators 
(6-13). Recently (6), we have examined the phenotypic, functional, and morpho- 
logical characteristics of the lymphoblasts generated in a mixed lymphocyte/ 
tumor cell response (MLTR) culture using peripheral blood mononuclear cells 
as responders and an allogeneic B cell line as the stimulator. In these cultures, 
the predominant cell type was a CD3 + T lymphoblast. Typically, only 5-15% of 
the total lymphoblasts expressed the NK cell-associated antigen, Leu-11. Anti- 
gen-specific cytotoxicity against he stimulating B cell line was mediated by a 
typical CD3 + cytotoxic T lymphoblast. In contrast, the majority of the cells 
mediating non-MHC-restricted cytotoxicity against the NK-sensitive tumor 
K562 expressed the Leu-11 antigen and lacked pan T cell-associated markers 
(6). The Leu-11 + cells isolated from these MLTR cultures demonstrate enhanced 
cytotoxic activity against NK-sensitive and -insensitive tumor cells, and blast 
morphology; inaddition, they express antigens associated with cellular activation, 
e.g., class II MHC antigens and transferrin receptor (6). Interferon and interleu- 
kin 2 (IL-2) efficiently enhance NK cell-mediated cytotoxicity (14-21), and cell 
t Abbreviations used in this paper: CRs, complement receptor type 3; E/T, effector/target; FACS, 
fluorescence-activated cell sorter; FITC, fluorescein isothiocyanate; IL-2, interleukin 2; LGL, large 
granular lymphocytes; mAb, monoclonal ntibody; MHC, major histocompatibility complex; MLTR, 
mixed lymphocyte/tumor response; NK, natural killer; PE, phycoerythrin; PHA, phytohemaggluti- 
nin. 
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lines with NK cell characteristics have been established using IL-2 as growth 
factor (22-25). Since interferons and IL-2 are present in high concentration i
mixed lymphocyte response (MLR) cultures, it seemed likely that activation of 
the Leu-11 + cells resulted from a response to these soluble factors. However, it 
was unresolved whether NK cells in the MLTR could directly respond against 
the stimulator. 
In the present experiments, we have questioned whether NK cells can be 
activated by direct stimulation with the NK-sensitive tumor cell line, K562. Using 
highly purified populations of  NK (Leu-11 +) and T (Leu-11-) lymphocytes, we 
observed that Leu-11 + cells were activated when cocultured with mitomycin C-  
treated K562 cells. This activation process resulted in proliferation, enhanced 
cytotoxic activity, and expression of  activation antigens, such as transferrin 
receptor and class II MHC antigens. The  activation was a direct consequence of
interactions between Leu- l l  + cells and K562. Exogenous growth factors or 
accessory cells were not required. Previously (2), we demonstrated that Leu-11 + 
lymphocytes could be divided into discrete subpopulations on the basis of  Leu-7 
antigen expression. We now report that expression of the Leu-7 antigen can be 
induced in the Leu-7+l 1 + subset by activation with K562. In contrast, stimulation 
of  the Leu-7+l 1 + cells with K562 did not affect the antigenic phenotype. These 
data establish a developmental relationship between the Leu-7-11 ÷ and Leu- 
7+11 + cells and are consistent with the possibility that Leu-7 is a differentiation 
antigen that appears late in the development of NK cells. 
Mater ia ls  and Methods  
Preparation of Human Peripheral Blood Leukocytes. Human peripheral blood from 
randomly chosen normal donors was obtained from the American Red Cross, San Jose, 
CA or the Stanford Blood Center, Palo Alto, CA. Mononuclear cells were isolated using 
Ficoll/Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) by standard methods. Cells 
were washed extensively in phosphate-buffered saline (0.1 M phosphate, pH 7.3). 
Enrichment of LGL. Monocytes were depleted from the peripheral blood mononuclear 
cells by adherence to plastic tissue culture flasks (26). B lymphocytes and residual adherent 
cells were removed by passing the cells through nylon wool (26). Nylon wool-nonadherent 
cells were layered onto a cushion of 43.5% Percoll, centrifuged for 50 min at 300 g, and 
the low density fraction was harvested from the gradient interface. We have demonstrated 
(26), using this procedure, that essentially all lymphocytes with NK activity are contained 
in the low density fraction. Typically, ~30-60% of the low density lymphocytes xpressed 
the NK cell-associated antigen, Leu-11, whereas ~40-70% expressed the pan T cell 
antigen, CD3, depending on the individual donor. 
Monoclonal Antibodies. All antibodies were prepared by the Becton Dickinson Mono- 
clonal Center, Inc. Anti-Tac (IL-2 receptor) mAb was generously provided by Dr. T. 
Waldmann, National Institutes of Health (27). Anti-Leu-4 mAb recognizes the pan T cell 
antigen CD3. Anti-Leu-11 reacts with an antigen (CD 16) associated with the Fc receptor 
for IgG present on essentially all NK cells and neutrophils (2, 5). Anti-Leu-2a nd anti- 
Leu-3a react with the CD8 and CD4 antigens, respectively. Anti-Leu-7 reacts with a subset 
of NK cells (2, 28). Anti-Leu-15 reacts with an antigen associated with the complement 
receptor type 3 (CRy) (L. Lanier and G. Ross, unpublished observation). Anti-Leu-M3 
reacts with an antigen exclusively present on monocytes. The CD nomenclature for 
human differentiation antigens, proposed by the International Workshop on Human 
Leukocyte Differentiation Antigens (29) and approved by the World Health Organization, 
will be used to describe the T cell differentiation a tigens discussed in this paper. 
Immunofluorescence and Flow Cytometry. Immunofluorescent staining procedures have 
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been described previously (2, 30). Fluorochrome-conjugated, isotype-matched mAb that 
did not specifically react with human cells were used to control for nonspecific binding. 
Immunofluorescence was measured using a fluorescence-activated c ll sorter (FACS) 
(FACS 440; Becton Dickinson Immunocytometry Systems, Mountain View, CA). Methods 
of flow cytometry have been described in detail elsewhere (2, 30). 
Tumor Cells. All tumor cell lines were obtained from the American Type Culture 
Collection, Rockville, MD and were tested monthly to ensure against mycoplasma contam- 
ination. 
In Vitro Stimulation of Lymphocytes Subsets. Lymphocytes were cocultured with mito- 
mycin C-treated (80 ~g/ml, 1 h) tumor cells in RPMI 1640 (Irvine Scientific, Santa Ana, 
CA) supplemented with 5% heat-inactivated horse serum (JR Scientific, Woodland, CA), 
1 mM glutamine (Gibco Laboratories, Grand Island, NY), and antibiotics (complete culture 
medium). Responder cells in complete culture medium (0.5-5 × 106/ml) were mixed with 
stimulator cells (0.1-1.0 × 106/ml) to achieve a ratio of 5:1. Cells were placed into 96- 
well round-bottom or 24-well plastic tissue culture plates (Falcon Plastics, Oxnard, CA). 
Lymphocytes (1 × 106/ml) in complete culture medium were stimulated with phytohe- 
magglutinin (PHA-M) (Gibco Laboratories) ata concentration f 2% (wt/vol). Lymphocyte 
proliferation was measured by incorporation of [~H]thymidine. Cultures were pulsed 
overnight with 1 uCi [gH]thymidine (Amersham Corp., Arlington Heights, IL), and the 
cells harvested using a PHD Celt Harvester (Cambridge Technology, Inc., Cambridge, 
MA). Samples were placed in vials containing Complete Counting Cocktail 3a20 (Research 
Products International Corp., Mt. Prospect, IL) and the radioactivity determined using 
an LS 7800 liquid scintillation counter (Beckman Instruments, Inc., Fullerton, CA). The 
mean of triplicate samples was used for all statistical evaluation. 
Cytotoxicity Assays. Tumor cells were labeled with 5~Cr and were used as targets in a 4- 
h radioisotope r lease cytotoxicity assay, as described previously (2). 
Morphology. Cells were cytocentrifuged onto ethanol-cleaned glass slides. The speci- 
mens were fixed in absolute methanol for 10 min, air dried, stained in a 10% aqueous 
solution of Giemsa for 10 min, and washed in distilled water. 
Results 
Stimulation of Leu-l l -  and Leu-l l + Lymphocytes With K562. Peripheral blood 
lymphocytes from randomly selected normal individuals, depleted of monocytes 
by adherence, were stained with fluorescein isothiocyanate (FITC)-conjugated 
anti-Leu-11 a mAb. ~ 10-20% of the lymphocytes were antigen positive, depend- 
ing on the donor. Lymphocytes were sorted into Leu-11- and Leu-11 ÷ fractions 
using a FACS. The  isolated subpopulations, >90% pure as determined by 
reanalysis, were cocultured with an NK-sensitive tumor cell line, K562, or a 
relatively NK-insensitive B cell line, CCRF-SB. The  stimulator cell lines were 
treated with mitomycin C to prevent cell division. Proliferation by the responder 
cells was measured on day 6 by [3H]thymidine incorporation. Leu- l l  + cells 
significantly proliferated in response to coculture with K562, but usually not 
CCRF-SB (Table I). In contrast, Leu-11- lymphocytes strongly proliferated in 
response to the B cell line CCRF-SB, but reacted only weakly against K562. This 
preferential activation of  Leu-1 ! + cells against K562 was observed in all donors, 
although the magnitude of  the response varied (Table I). Kinetic studies revealed 
that the proliferative response of  both the T lymphocytes against CCRF-SB and 
the NK cells against K562 peaked on day 5 of  culture (Fig. 1). 
Cells harvested after 6 d of  coculture with K562 were examined by flow 
cytometry for light scatter characteristics and expression of surface differentia- 
tion antigens. As shown in Fig. 2, lymphocytes that expressed the Leu-11 antigen 
before coculture with K562 retained Leu-11 expression after 6 d. Similarly, all 
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TABLE I 
Proliferation of Leu-11 + and Leu-I I -  Lymphocytes Cocultured With K562 
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[SH]thymidine Stimula- 
Exp. Responder Stimulator incorporation tion in- 
dex 
cpm 
1 Leu-11- - -  431 ± 109 - -  
Leu-11 + - -  321 ± 57 - -  
Leu-I  1- K562 1,549 ± 312" 3.6 
Leu-11 ÷ K562 10,523 ± 814 32.8 
Leu-11-  CCRF-SB 5,844 ± 114 13.6 
Leu-11 ÷ CCRF-SB 143 ± 72 0 
Leu- l l -  - -  580 ± 150 - -  
Leu- l l  ÷ - -  610 ± 56 - -  
Leu- l l -  K562 1,600 ± 200 2.7 
Leu- l l  + K562 16,120 ± 240 26.4 
Leu- l l -  - -  820 ± 110 - -  
Leu- l l  ÷ - -  341 ± 120 - -  
Leu- l l -  K562 3,280 ± 260 4.0 
Leu- l l  ÷ K562 6,138 ± 220 18.0 
Peripheral blood mononuclear  celts were stained with F1TC anti-Leu-1 la mAb, 
then separated into Leu-11-  and Leu-11 ÷ lymphocyte subpopulations using a 
FACS. Reanalysis of  the sorted cells indicated >95% purity. Lymphocytes were 
cocultured with or without mitomycin C- t reated K562 or CCRF-SB tumor  
cells, as indicated. The  culture wells were pulses overnight with 1 gCi [~H]- 
thymidine and harvested after 6 d culture. 
* Background thymidine incorporation by the mitomycin C-t reated K562 or 
CCRF-SB tumor  cells ( tumor inactivation control) was subtracted from the raw 
counts to determine the specific incorporation by the effector cell population. 
Stimulation index: (cpm with st imulator)/(cpm without stimulator). 
K562 MLR CCRF-SB MLR 
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FIGURE 1. Kinetics of  proliferative response. Peripheral blood mononuclear  cells were 
stained with F ITC  anti-Leu-1 la mAb and separated into Leu-11- and Leu-11 ÷ lymphocyte 
subpopulations using a FACS. Reanalysis indicated >95% purity. >99% of  the sorted cells 
were lymphocytes by morphological criteria. Leu- i  1- and Leu-11 ÷ lymphocytes were cocul- 
tured with mitomycin C- t reated K562 (K562 MLR) or CCRF-SB (CCRF-SB MLR) cells in 
96-welt microtiter plates. Cultures were pulsed overnight with [3H]thymidine and harvested 
oil days 3, 5, and 7. The  stimulation index is defined as: (cpm with stimulator)/(cpm without 
stimulator). 
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FIGURE 2. Blastogenesis and expression of activation antigens on lymphocyte subsets co- 
cultured with K562. Peripheral blood mononuclear cells were stained with FITC anti-Leu- 
1 la mAb and separated into Leu-11- and Leu-11 + lymphocyte subpopulations u ing a FACS. 
Reanalysis ndicated >90% purity. >99% of the sorted cells were lymphocytes by morphological 
criteria. Leu-11- (left) and Leu-11 + (right) lymphocytes were cocuhured with mitomycin C-  
treated K562 in 24-well culture plates. After 6 d, cells were harvested and stained with: FITC 
IgG and PE IgG control antibodies; FITC anti-Leu-1 la and PE anti-Tac; or FITC anti-Leu- 
1 la and PE anti-HLA-DR. In the upper panels, histograms displaying the forward angle light 
scatter are presented (x axis, 256 channels, linear scale; y axis, relative number of cells). 
Forward angle light scatter measurements e sentially reflect cell size for lymphoid cells (31). 
In the lower panels, correlated measurements of green (x axis, log scale) and red (y axis, log 
scale) fluorescence are displayed as two-dimensional contour plots (2, 30). Based on the control 
sample, the contour plots were divided into quadrants: I, cells with red fluorescence only; lI, 
ceils with green and red fluorescence; III, unstained cells; and IV, cells with green fluorescence 
6nly. The number of cells in each area was integrated and the percentage of the total cells was 
determined. In the control samples, <5% of the lymphocytes were nonspecifically stained (i.e., 
present in quadrants I, II, and IV). In the population of Leu-11- cells cocultured with K562 
(left), <5% expressed the Leu-11 antigen. 31.7% of the cells were Leu-11-, DR + and <5% 
were Leu-11-, Tac +. In contrast, after stimulation of the Leu-11 + cells with K562, -85-90% 
of these cells expressed Leu-11 antigen and 25.9% coexpressed Leu-11 and DR antigen. <5% 
of the Leu-11 + lymphocytes coexpressed Leu-11 and Tac antigen. (It should be noted that the 
density of Leu-I 1 antigen decreases after activation and may lead to underestimation f the 
percentage of dimly stained Leu-11 + cells). 
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lymphocytes that lacked Leu-11 antigen before coculture with K562 were Leu- 
11- after 6 d. Thus, there was no evidence for acquisition or loss of  this antigen 
as a consequence of stimulation with K562. A proportion of  the Leu-11 + cells 
coexpressed HLA-DR antigen (25% in Fig. 2) and transferrin receptor (not 
shown) after coculture with K562. Before culture, <1% of Leu-11 ÷ cells coex- 
pressed HLA-DR or transferrin receptor, indicating that class II MHC antigens 
and transferrin receptor were induced as a consequence of activation. Further 
evidence for activation of the Leu-11 + cells was obtained by examining the 
forward angle light scatter properties of  these cells. For lymphoid cells, light 
scatter is essentially proportional to cell size (31). In contrast o the Leu-11- cells 
that proliferated only weakly in response to coculture with K562, a majority of  
the Leu-11 + cells demonstrated light scatter characteristics similar to mitogen- 
activated lymphoblasts (Fig. 2). This was confirmed by microscopic examination. 
A majority of  the K562-activated Leu-11 + cells were lymphoblasts with abundant 
cytoplasm and azurophilic granules (not shown). IL-2 receptor-associated anti- 
gen, Tac, was not detected on these Leu-11 ÷ lymphoblasts (Fig. 2). Similar results 
were obtained in three independent experiments. 
A more extensive antigenic profile of  the K562-activated Leu- 11 + lymphoblasts 
is presented in Fig. 3. A proportion of the Leu-11 + lymphoblasts coexpressed 
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FIGURE 3. Antigenic pbenotype ofLeu-I 1 + lymphocytes after coculture with K562. Purified 
Leu-1 l+ lymphocytes were cocultured with mitomycin C-treated K562 cells, as described in
Fig. 2 After 6 d, viable cells were recovered and stained with: FITC IgG and PE IgG control 
antibodies; FITC anti-Leu-7 and PE anti-Leu-1 lc; FITC anti-Leu-1 la and PE anti-Leu-2; 
FITC anti-Leu-1 la and PE anti-Leu-4; FITC anti-Leu-I la and PE anti-CR3(Leu-15); and 
FITC anti-Leu-1 la and PE anti-Leu-M3. Data are presented as described inFig. 3. Quantita- 
tion of the results revealed: 43.7% Leu-ll+7+; 43.3% Leu-1 I+7-; <5% Leu-ll-7 +. 26.3% 
Leu-ll+2+; 56.8% Leu-11+2-; 8.6% Leu-11-2 + . <5% Leu-ll+4+; 83.5% Leu-11+4-; <5% 
Leu-11-4 +. 17.5% Leu-11+CRs+; 67.6% Leu-11+CR3-; 6.3% Leu-11-CRs +. <5% Leu-1 l+M3+; 
85.3% Leu-1 l+M3-; <5% Leu-1 l-M3 +. >95% of the cells in the IgG control sample were 
unstained (quadrant lII). 
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Leu-2 (CD8), Leu-7, and Leu-15 (CR3 associated) antigens. These antigens are 
expressed on subpopulations of resting Leu-! 1 + ceils isolated from fresh blood 
(2, 32). The only notable difference between the freshly isolated Leu-11 + cells 
and the activated Leu-11 + lymphoblasts was that the cell surface density of Leu- 
15 apparently decreases during culture. Similarly, we observed that the density 
of Leu-11 antigen decreases after activation. Leu-M3, an antigen expressed on 
most monocytes, and Leu-4 (CD3), an antigen associated with the T cell antigen 
receptor complex, were not detected on the K562-activated Leu-11 + lympho- 
blasts (Fig. 3). 
The cytotoxic activity of the Leu-11- and Leu-11 + cells was determined after 
coculture with or without mitomycin C-treated K562 cells for 6 d. Leu-11- 
lymphocytes cocultured with K562 usually demonstrated minimal cytotoxicity 
against K562 (Fig. 4), although low levels of cytotoxicity were occasionally 
observed in some individuals. Lymphoblasts derived from cocultures of Leu-11 + 
lymphocytes and K562 were significantly more cytotoxic against K562 than Leu- 
11 + cells cultured for 6 d without K562 (Fig. 4). Moreover, the K562-activated 
Leu-I 1 + lymphoblasts were highly cytotoxic at low effector-to-target (E/T) ratios 
for a broad range of tumor cell targets, including U937, CEM, HSB-2, CCRF- 
SB, HUT-78, and K562. (Fig. 5). 
Stimulation of Subsets Identified by Expression of the Leu-7 and Leu-ll Anti- 
gens. Peripheral blood lymphocytes can be divided into at least four distinct 
subpopulations based on the expression of the Leu-7 and Leu-11 surface antigens; 
i.e., Leu-7-11 +, Leu-7+l 1 +, Leu-7+l 1-, and Leu-7-11- (2). Lymphocytes, en- 
riched for LGL by centrifugation on Percoil gradients, were stained with FITC 
anti-Leu-1 la and phycoerythrin (PE)-avidin/biotin anti-Leu-7. The four subpop- 
ulations were separated using two-color FACS procedures and were cocuhured 
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FIGURE 4, Cytotoxic activity of Leu- 11- and Leu- l 1 + lymphocytes after coculture with K562, 
Leu-11- and Leu-11 + lymphocytes were cocultured with (MLTR/K562) or without (control) 
mitomycin C-treated K562 cells, as described in Fig. 2. After 6 d, viable cells were isolated 
and tested for cytotoxic activity against K562 and CCRF-SB in a 4 h radioisotope release assay. 
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FIGURE 5. Cytotoxicity of activated Leu-] 1 + lymphocytes. Leu-11 ÷ lymphocytes were cocul- 
tured with mitomycin C-treated K562 cells for 6 d, as described in Fig. 2. Viable cells were 
isolated and tested for cytotoxic activity against K562, CCRF-SB, U937, CEM, HUT-78, and 
HSB-2 tumor cell targets in a 4 h radioisotope r lease assay. Unstimulated Leu-11 + lymphocytes 
and Leu-I 1- lymphocytes did not lyse (<5%) any of these targets at comparable E/T ratios 
(not shown). 
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Proliferation of lymphocytes xpressing the Leu-7 and/or Leu-11 antigens cocul- 
tured with K562. Nylon wool-nonadherent peripheral blood lymphocytes, enriched for NK 
cells using Percoll (Materials and Methods), were stained with FITC anti-Leu-1 la and PE- 
avidin/biotin antiLeu-7. The resulting four subsets were separated by two-color FACS sorting. 
Reanalysis of the isolated populations indicated that all subsets were >95% pure. The cells 
were cocuhured with or without mitomycin C-treated K562 cells in 96-well round-bottom 
plates for 6 d. Cultures were pulsed overnight with 1 #Ci [SHlthymidine and harvested. 
wi th mi tornyc in  C - t reated  K562 cells. A f te r  6 d o f  cu l tu re ,  p ro l i fe ra t ion  was 
measured  by [3H] thymid ine  incorporat ion  (Fig. 6). Both  the  Leu-7+l  1 + and  Leu-  
7-1 1 + pro l i fe ra ted  in response  to K562,  wi th  the  la t te r  popu la t ion  cons is tent ly  
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demonstrating significantly higher levels of proliferation (2-10-fold higher in 
three experiments, depending on the donor). The Leu-7+l 1- and Leu-7-11- 
lymphocytes were weakly stimulated by K562, although significant proliferation 
was observed in some donors (e.g., Table II, experiment 2). The anti-Leu-7 and 
anti-Leu-11 antibodies were not mitogenic for these cell populations, as demon- 
strated by the lack of proliferation in the cultures without K562 (Fig. 6). 
Furthermore, when Percoll gradient-enriched LGL were stained with anti-Leu- 
7 and anti-Leu-11 antibodies before cocuhured with mitomycin C-treated K562 
cells, the stimulation index was essentially identical to the response of LGL not 
stained with these antibodies. Therefore, it is unlikely that using these mAb for 
isolation of these subpopulations significantly influenced their response. 
Analysis of the cytotoxic activity of the subpopulations after culture with K562 
indicated that the Leu-7-11 + and Leu-7+l 1 + cells were both potent cytotoxic 
effectors. The Leu-7-11- and Leu-7+l 1- lymphocytes cocultured with K562 
demonstrated minimal cytotoxic activity against K562 (Fig. 7). Previously (2), we 
demonstrated that the anti-Leu-7 and anti-Leu-11 antibodies do not affect the 
cytotoxic function mediated by NK cells. 
With respect o antigenic phenotype, we consistently observed that a significant 
proportion (20-40% in three independent experiments, depending on the donor; 
37.7% in Fig. 8) of the Leu-7-11 + cells acquired expression of Leu-7 antigen 
after stimulation with K562 (Fig. 8). It is unlikely that the appearance of the 
Leu-7+l 1 + cells in the Leu-7-11 ÷ population after stimulation with K562 resulted 
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FIGURE 7. Cytotoxic activity of lymphocytes xpressing the Leu-7 and/or Leu-11 antigens 
cocuhured with K562. Lymphocyte subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated by two-color FACS sorting and cocuhured with mitomycin C-treated K562 cells, as 
described in Fig. 6. After 6 d, the viable cells were harvested and tested for cytotoxic activity 
against K562 and CCRF-SB using a 4 h radioisotope r lease assay. 
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FIGURE 8. Antigenic profile of lymphocytes expressing the Leu-7 and/or Leu-11 antigens 
cocultured with K562. Lymphocyte subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated by two-color FACS cell sorting. Reanalysis of the purified populations are shown in 
the left panels (sorted day 0). All populations were >90% pure. These cells were cocultured 
with mitomycin C-treated K562. After 6 d, the viable cells were recovered and stained with 
FITC anti-Leu-I la and PE-avidin/biotin anti-Leu-7. Data are presented as described in Fig. 
2. <5% of the cells in the Leu-7-11- population expressed the Leu-7 and/or Leu-I 1 antigen 
after coculture with K562.95% of the Leu-7+l 1 + cells coexpressed both antigens before and 
after stimulation with K562. In contrast, 37.7 % of the Leu-7-11 + cells demonstrated xpression 
of Leu-7 after stimulation with K562. The small proportion of Leu-7-11- cells (14.9%) shown 
in the Leu-7+l 1- population after coculture with K562 was not observed in three subsequent 
experiments, and was likely explained by expansion or preferential survival of the 5% 
contamination f this population with Leu-7-11- cells during the sort. 
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from outgrowth of contaminating Leu-7+l I + cells, since reanalysis immediately 
after the sort indicated <1% contamination with Leu-7+ll + cells in the Leu- 
7-11 + sorted fraction (Fig. 8). Additionally, the growth rate of the Leu-7-11 + 
population was approximately twice that of the Leu-7+l 1 + population (Fig. 6). 
The antigenic phenotype of the Leu-7+l 1 + cells was unaffected by stimulation 
with K562; i.e., both Leu-7 and Leu-11 antigens were retained on essentially all 
cells (95%). Similarly, the Leu-7+l 1- cells neither gained expression of the Leu- 
11 antigen or lost expression of Leu-7 as a consequence of coculture with K562 
in three of four experiments (Fig. 8). Expression of the Leu-7 or Leu-11 antigens 
was not induced on cells in the Leu-7-11- population after K562 coculture (Fig. 
8). Consistent results in the proliferation, cytotoxic, and antigenic phenotype 
assays were obtained in three experiments u ing blood from independent donors. 
The lymphocyte subsets defined by Leu-7 and Leu-11 antigen expression, 
isolated to >95% purity by two-color FACS sorting, were stained with Giemsa 
and morphologically examined. The Leu-7-11 + and Leu-7+ll + subsets were 
homogeneous populations of typical LGL with prominent azurophilic granules 
(Fig. 9, A and C). After coculture with K562 for 6 d, the majority of cells in both 
subpopulations revealed primarily blast morphology, with abundant cytoplasm, 
numerous azurophilic granules, and large lobular euchromatic nuclei (Fig. 9, B 
and D). -10-20% of the Leu-7-11 + and Leu-7+l 1 + cells cocuitured with K562 
displayed typical mitotic configurations (Fig. 9, B and D). 
The Leu-7+l 1- cells, although also morphologically LGL, were generally 
smaller in size and consistently contained fewer azurophilic granules than either 
the Leu-7+l 1 + or Leu-7-11 + cells (Fig. 9E). Leu-7-11- cells were, morphologi- 
cally, typical agranular small lymphocytes. After coculture with K562 for 6 d, 
the morphology of most Leu-7+l 1- and Leu-7-11- cells remained essentially 
unchanged (Fig. 9, F and H). However, a small percentage (5-10%) of cells with 
blast morphology were observed. 
Inhibition of Stimulation by mAb. To determine the role of IL-2 receptors in 
the activation of granular lymphocytes by K562, anti-Tac (IL-2) receptor mAb 
or an isotype-matched nonreactive control IgG antibody were added to cocultures 
of mitomycin C-treated K562 and lymphocyte subpopulations, i olated by two- 
color cell sorting with FITC anti-Leu-lla and PE-avidin/biotin anti-Leu-7. 
Results from two independent donors are presented inTable II. The proliferative 
response of the Leu-7-11 + against K562 was minimally inhibited (9%, Exp. 1; 
6%, Exp. 2), whereas the response of the Leu-7+l 1 + was partially inhibited (17%, 
Exp. 1; 18%, Exp. 2) by anti-Tac. In contrast, the mitogenic response of the T 
lymphocytes (Leu-7-11-) from both donors was completely inhibited (98%) by 
anti-Tac. Furthermore, the proliferation in the Leu-7-11-and Leu-7+l 1- cells 
against K562 in Exp. 2 also was completely inhibited by anti-Tac, suggesting that 
a different mechanism ay be involved in the response of Leu-11- and Leu-11 + 
FIGURE 9. Morphology of lymphocytes expressing the Leu-7 and/or Leu-11 antigens after 
coculture with K562. Lymphocytes subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated to >95% purity by two-color FACS cell sorting. Immediately after sorting (A, C, E, 
and G) or after 6 d of coculture with mitomycin C-treated K562 (B, D, F, and H), Leu-7-11 + 
(A, B), Leu-7÷l 1 + (C, D), Leu-7+l 1- (E, F), and Leu-7-11- (G, H) were stained with Giemsa 
and examined by light microscopy, x 4,500. 
1475 
1476 DIFFERENTIAT ION OF HUMAN NATURAL KILLER CELLS 
TABLE I I  
Inhibition of Proliferation by mAb 
Stimula- 
Percent Responder Stimulator Antibody [3H]thymidine tion in- 
inhibition 
dex 
cpm 
Exper iment 1
Leu-7-11 + None None 200 - 120 - -  - -  
Leu-7-11 ÷ K562 Control IgG 9,300 + 230* 46.5 - -  
Leu-7-11 ÷ K562 Anti-Tac 8,515 - 115 42.6 9% 
Leu-7+l 1 + None None 507 + 213 - -  - -  
Leu-7+l 1 ÷ K562 Control IgG 7,500 -+ 120 14.8 - -  
Leu-7+l 1 + K562 Anti-Tac 6,318 - 198 12.5 17% 
Leu-7+l 1- None None 815 + 180 - -  - -  
Leu-7+l 1- K562 Control IgG 1,725 - 271 2.1 - -  
Leu-7+l 1- K562 Anti-Tac 891 - 176 1.1 92% 
Leu-7-11-  N None 1,600 + 223 - -  - -  
Leu-7-11-  K5t~, Control IgG 2,541 - 211 1.6 - -  
Leu-7-11-  K562 Anti-Tac 1,640 __+ 142 1.0 96% 
Leu-7-11-  PHA Control IgG 48,113 + 416 30.1 - -  
Leu-7-11-  PHA Anti-Tac 1,988 +1 260 1.2 98% 
Experiment 2 
Leu-7-11 + None None 420 -+ 162 - -  - -  
Leu-7-11 ÷ K562 Control IgG 12,810 + 260 30.5 - -  
Leu-7-11 ÷ K562 Anti-Tac 11,989 - 191 28.5 6% 
Leu-7+l 1 t None None 342 + 200 - -  - -  
Leu-7+l 1 ÷ K562 Control IgG 6,580 _ 190 19.2 - -  
Leu-7+l 1 + K562 Anti-Tac 5,420 + 240 15.8 18% 
Leu-7+l 1- None None 500 + 170 - -  - -  
Leu-7+l 1- K562 Control IgG 3,260 + 203 6.5 - -  
Leu-7+l 1- K562 Anti-Tac 620 + 198 1.2 96% 
Leu-7-11- None None 921 + 260 - -  - -  
Leu-7-11- K562 Control IgG 6,824 --+- 211 7.4 - -  
Leu-7-11- K562 Anti-Tac 1,231 -+ 210 1.3 95% 
Leu-7-11- PHA Control IgG 18,420 + 341 20 - -  
Leu-7-11- PHA Anti-Tac 1,332 - 240 1.4 98% 
Leu-7 and Leu-11 subpopulations isolated by FACS sorting, as described in Fig. 6, were stimulated 
by coculture with K562 or PHA. Anti-Tac antibody and nonreactive IgG control antibodies were 
added to the cultures at a final concentration of 150 #g/ml.  Cultures were pulsed overnight with 
1 #Ci [3H]thymidine and were harvested on day 6. The stimulation index is defined in Table I. 
* Background thymidine incorporation by the mitomycin C- t reated K562 or CCRF-SB tumor cells 
(tumor inactivation control) was subtracted from the raw counts to determine the specific incor- 
poration by the effector cell population. Percent inhibition is defined as: 100 × [(cpm with K562 
and control IgG - cpm without stimulator and antibody) - (cpm with K562 and anti-Tac - cpm 
without st imulator or antibody)/(cpm with K562 and control IgG - cpm without stimulator or 
antibody)]. 
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cells against K562. As described previously (14), anti-Tac antibody did not inhibit 
the cytotoxic activity of NK cells. 
Discussion 
Leu-11 + lymphoblasts (6) were a minor population in MLTR cultures using 
an allogeneic B cell line as the stimulator. In general, allogeneic B cell lines are 
relatively insensitive to NK-mediated cytotoxicity. We questioned whether Leu- 
11 + cells could be preferentially stimulated if an NK-sensitive tumor cell line was 
used as the stimulator in an MLTR culture. Poros and Klein (33) have reported 
that coculture of peripheral blood mononuclear cells with an NK-sensitive tumor 
cell, K562, results in the preferential activation of lymphoblasts hat express Fc 
receptors and are highly cytotoxic for K562. In contrast (33), stimulation with 
allogeneic peripheral blood lymphocytes preferentially stimulates typical E ro- 
sette-positive lymphoblasts hat lack Fc receptor expression. We have confirmed 
these observations (34). Coculture of mitomycin C-treated K562 with either 
unseparated peripheral blood lymphocytes or Percoll gradient-enriched low 
density lymphocytes results in proliferation and activation of cells expressing the 
Leu-11 antigen, but usually lacking pan T cell antigens (34). Depletion studies 
(34) with antibody and complement show that the peripheral blood precursor of 
the activated Leu-11 + cell expresses the Leu-11 antigen. The structure on K562 
responsible for activation of NK cells is unknown, but it is important o note that 
K562 lacks expression of both class I and II MHC antigens on the cell surface. 
We do not know if K562 cells stimulate NK cells through release of a soluble 
product, but are exploring this possibility. 
An important unresolved issue was whether or not NK cells could be stimulated 
directly by coculturing purified Leu-11 + cells with K562. We have demonstrated 
that it is possible to selectively stimulate Leu-11 + and Leu-11- responders with 
K562 and CCRF-SB, respectively. Stimulation of the highly purified Leu-11 + 
cells with K562 resulted in blastogenesis, enhanced cytotoxicity against NK- 
sensitive and -insensitive targets, and egpression of cell surface activation antigens 
(class II MHC antigens and transferrin receptor) on a portion of the cells. The 
observation that Leu-11 + granular lymphocytes were preferentially stimulated 
by K562 implies that NK cells can demonstrate specificity in the recognition 
process. These experiments also suggest hat Leu-11 + cells may be capable of 
stimulation and proliferation in the absence of T lymphocytes, exogeneous 
growth factors, or accessory cells. However, the possibility that a small number 
of contaminating monocytes (<1%) or T lymphocytes (<5%) influenced the 
response of the Leu-11 + lymphocytes against K562 cannot be excluded. We are 
currently investigating the influence of adding monocytes and T cells to the 
cultures, and determining the range of tumor cell lines that are capable of 
initiating activation. 
The relationship between NK cells and T lymphocytes has been a controversial 
issue. The arguments range from the view that cytotoxic T cells "degenerate" 
into NK cells, to the idea that NK cells are primitive T lymphocytes that do not 
require thymic processing. We have been unable to induced expression of Leu- 
I1 antigen by coculturing purified T (Leu-1 I-) lymphocytes with K562. Al- 
though, typically, there was little cytotoxic or proliferative activity in the Leu- 
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11- population after stimulation with K562, we observed significant levels of 
proliferation and cytotoxicity in some individuals. This is consistent with reports 
that some IL-2-dependent clones that express T cell antigen receptor and CD3 
antigen, but lack Fc receptors (Leu-11), can lyse NK-sensitive tumors (22-25). 
By contrast, essentially all Leu- l l  + cells stimulated by coculture with K562 
retained expression of Leu-11 antigen, were highly cytotoxic for NK-sensitive 
and -insensitive tumor cells, and usually did not acquire expression of the pan T 
cell antigens, CD3. The relationship between the K562-reactive CD3 ÷ lympho- 
cytes and Leu-11 + lymphocytes i  unknown. 
Within the LGL population there is considerable heterogeneity in expression 
of cell surface antigens (2, 3, 28, 32, 34, 35). Previously, we (2) and other 
investigators (36) have demonstrated that four distinct subsets of lymphocytes 
can be defined by expression of the Leu-7 and/or Leu-11 antigens. These subsets 
were purified and cocultured with K562. One interpretation consistent with the 
data is that the Leu-7 antigen appears late in the differentiation of NK cells. 
This relationship is depicted in Fig. 10. In this model, the Leu-7-11 + cells, when 
activated with an appropriate signal such as stimulation with K562, rapidly 
proliferate, regenerating more cells with the Leu-7-11 + phenotype and some 
cells that acquire the Leu-7 antigen. Our experiments unequivocally demonstrate 
that Leu-7+l 1 + lymphocytes can arise from Leu-7-11 + precursors, and that there 
is a developmental relationship between these two phenotypically distinct subsets. 
Based on the observation that Leu-7+l 1 + cells derived from peripheral blood 
consistently demonstrate lower proliferative capacity than the Leu-7-11 ÷ cells, 
we conclude that these cells may represent an NK cell that is more mature and 
has less regenerative capacity than the Leu-7-11 ÷ cell. 
Abo and colleagues (36, 37) have proposed that the Leu-7 antigen is an early 
marker of NK cell differentiation and that the Leu-7+l 1- population may 
represent a "pre-NK" cell. They have predicted that the Leu-7+l 1- cells acquire 
the Leu-11 antigen during maturation and that the Leu-7 antigen may be lost 
upon activation of the Leu-7+l 1 + subset (36). This interpretation is inconsistent 
with results from aliogeneic MLTR experiments (6) and our present study. We 
have been unable to induce significant NK ceil-mediated cytotoxic function or 
FIGURE 10. A model for the differentiation f Leu-ll + lymphocytes. In this model, Leu- 
11 +7- lymphocytes can be activated by an appropriate stimulus, uch as interaction with K562 
cells. As a consequence, a proportion of the cells acquire activation antigens (e.g., HLA-DR 
and transferrin receptor, TFR). During the activation process, Leu-7-11 ÷proliferate, regen- 
erating more cells with this antigenic phenotype. Additionally, Leu-7 antigen isinduced on a 
proportion of the lymphocytes (20-40%). 
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expression of the Leu-11 antigen on the Leu-7+l 1- cells by stimulation with 
K562 or recombinant I L-2 (14). Thus, the relationship of the Leu-7+ 11- granular 
lymphocytes to Leu- l l  + cytotoxic NK cells is unclear. Another substantial 
difference between Leu-7+l 1- and Leu-11 + cells is that the former all express 
the CD3 antigen (2), a glycoprotein associated with the T cell antigen receptor 
complex (38, 39). At present, there is no direct experimental evidence that these 
Leu-7 +, CD3 + lymphocytes are developmentally related to the Leu-11 + lympho- 
cyte population. 
In this study, we also investigated whether anti-Tac (IL-2 receptor) mAb 
influenced the activation and proliferation of Leu-11 + cells in response to K562. 
Of  particular interest, anti-Tac only minimally inhibited the proliferation of Leu- 
7-11 + cells against K562 and only partially inhibited the response of Leu-7+l 1 + 
cells. Furthermore, anti-Tac mAb did not react with Leu-l l  + lymphoblasts 
stimulated with K562. In contrast, the PHA-induced mitogenic response of T 
(Leu-11-) cells from the same individual and the proliferative response of the 
Leu-11- cells against K562 was completely inhibited by anti-Tac antibody. These 
data imply either that IL-2 and the IL-2 receptor are not involved in Leu-11 + 
NK cell stimulation with K562 or that NK cells possess a distinct IL-2 receptor 
that cannot be regulated by antibodies against the Tac epitope. The latter 
possibility is supported by reports that anti-Tac antibody failed to inhibit the 
augmentation of NK activity by recombinant IL-2 (14, 20). We are investigating 
whether IL-2 is involved in the stimulation of Leu-11 + cells with K562. 
The observation that Leu-11 + lymphocytes can respond directly to an NK- 
sensitive tumor cell makes this assay an excellent model with which to study the 
function of NK cells. It should thus be possible to explore the heterogeneity in 
target cell recognition, surface structures involved in the activation process, and 
the pathway of differentiation. 
Summary 
A subpopulation of low density granular iymphocytes that express the natural 
killer (NK) cell-associated Leu-11 antigen (IgG Fc receptor) were stimulated 
directly by coculture with an NK-sensitive tumor cell, K562. T lymphocytes 
(Leu-11-) responded only weakly when cocultured with K562. The response of 
Leu-11 + cells apparently did not require exogeneous factors or accessory cells. 
The K562-activated cells retained expression of Leu-11 antigen, acquired acti- 
vation antigens, and were highly cytotoxic against NK-sensitive and -insensitive 
tumor cells. Anti-IL-2. receptor monoclonal antibody minimally inhibited the 
activation of Leu-11 + cells by K562, but completely inhibited the phytohemag- 
glutinin-induced activation of the Leu-11- cells from the same individual. Leu- 
11 + cells can be divided into Leu-7-11 + and Leu-7+l 1 + subpopulations using 
anti-Leu-7 antibody. These subsets were separated by two-color fluorescence- 
activated cell sorting and cocultured with K562. Proliferation by Leu-7-11 + cells 
was significantly greater than by Leu-11+7 +cells. Leu-7+l 1- granular lympho- 
cytes and T lymphocytes (Leu-7-1 I-) typically proliferated only weakly when 
cocultured with K562. A proportion of the Leu-7-11 + cells acquired Leu-7 
antigen after stimulation with K562, whereas the phenotype of Leu-7+l 1 +, Leu- 
7+11-, and Leu-7-11- subsets was unaffected. These results demonstrate a 
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developmental relationship between the Leu-7-11 + and Leu-7+l 1 + lymphocytes 
and suggest that Leu-7 antigen may be expressed late in the differentiation 
pathway of NK cells. The  direct activation of highly purif ied Leu-11 + cells by 
coculture with K562 provides an in vitro model with which to study the activation 
and maturat ion of human NK cells. 
We thank Mr. Keith Kelley and Mr. Glen Welch for expert assistance with the flow 
cytometry, Ms. An My Le for excellent echnical assistance, and Ms. Ginger Miller for 
secretarial ssistance. 
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